Support H.R. 9828: End Vaccine Carveout Act – Hold Pfizer & Moderna accountable for untested vaxx.

By | September 27, 2024

SEE AMAZON.COM DEALS FOR TODAY

SHOP NOW

H1: Alleged Bill Introduced to Strip Immunity from Pfizer and Moderna

Have you heard the latest news swirling around social media? A tweet from an account called died Suddenly claims that Congressman Paul Gosar has introduced a bill that would strip immunity from pharmaceutical giants Pfizer and Moderna. This controversial move would allow individuals to sue these companies for potential harms caused by the COVID-19 vaccines.

You may also like to watch : Who Is Kamala Harris? Biography - Parents - Husband - Sister - Career - Indian - Jamaican Heritage

According to the tweet, the bill, known as H.R. 9828 or the End the Vaccine Carveout Act, aims to hold Pfizer and Moderna accountable for any adverse effects or deaths resulting from their vaccines. This alleged development has sparked a wave of reactions online, with many people calling for their representatives to support the bill.

While this information is still unverified, the implications of such a bill are significant. If passed, it could set a precedent for holding pharmaceutical companies responsible for the safety and efficacy of their products. This would mark a major shift in the legal landscape surrounding vaccine mandates and public health policies.

The tweet urges individuals to contact their representatives and voice their support for H.R. 9828. By doing so, they can help push for greater accountability and transparency in the pharmaceutical industry. This alleged bill has reignited the debate over vaccine safety and the role of government regulation in protecting public health.

It’s important to approach this news with a critical eye, as the tweet does not provide any official sources or evidence to back up its claims. However, the mere possibility of such a bill raises important questions about the balance between corporate interests and public safety.

You may also like to watch: Is US-NATO Prepared For A Potential Nuclear War With Russia - China And North Korea?

The COVID-19 pandemic has brought into focus the power and influence of pharmaceutical companies in shaping public health policies. The alleged introduction of a bill to strip immunity from Pfizer and Moderna reflects growing concerns about the safety and efficacy of vaccines, as well as the accountability of the companies producing them.

As the debate over vaccine mandates and public health measures continues to unfold, it is crucial for individuals to stay informed and engaged in the political process. Whether or not H.R. 9828 becomes a reality, the conversation around vaccine safety and accountability is far from over.

In conclusion, the alleged bill introduced by Congressman Paul Gosar to strip immunity from Pfizer and Moderna is a contentious development that has sparked widespread debate and speculation. While the details of the bill are still unconfirmed, its potential implications for vaccine safety and corporate accountability are significant. As the public grapples with the ongoing challenges of the COVID-19 pandemic, this alleged bill serves as a reminder of the complex issues at play in the intersection of public health and corporate interests.

BREAKING: Congressman Paul Gosar has introduced a bill which strips immunity from Pfizer and Moderna, allowing them to be sued for killing people with the untested vaxx.

Call your representatives now to support H.R. 9828, the End the Vaccine Carveout Act!

It’s time to end Big

When it comes to the world of vaccines and pharmaceutical companies, there is always a lot of controversy and debate. Recently, a bill introduced by Congressman Paul Gosar has sparked a lot of discussion and raised some important questions. Let’s take a closer look at the bill and what it means for Pfizer and Moderna.

What is the Bill Introduced by Congressman Paul Gosar?

The bill introduced by Congressman Paul Gosar is called H.R. 9828, the End the Vaccine Carveout Act. This bill aims to strip immunity from Pfizer and Moderna, two major pharmaceutical companies, allowing them to be sued for any harm caused by their vaccines. This is a bold move that has the potential to change the landscape of the pharmaceutical industry.

Why is Stripping Immunity from Pfizer and Moderna Significant?

The immunity granted to pharmaceutical companies like Pfizer and Moderna is a controversial topic. On one hand, it protects these companies from legal action in case their vaccines cause harm. On the other hand, it can be seen as giving these companies a free pass to release vaccines without proper testing or accountability. By stripping this immunity, Congressman Gosar is holding these companies responsible for the safety and efficacy of their products.

What Does This Mean for the Vaccination Efforts?

With the introduction of this bill, there is a possibility that Pfizer and Moderna may have to face legal repercussions for any harm caused by their vaccines. This could have a significant impact on the vaccination efforts, as it may lead to increased scrutiny and regulation of vaccine development and distribution. It could also change the way pharmaceutical companies approach vaccine research and development in the future.

How Can People Support H.R. 9828, the End the Vaccine Carveout Act?

If you believe in holding pharmaceutical companies accountable for the safety of their vaccines, you can support H.R. 9828 by calling your representatives and urging them to vote in favor of the bill. By voicing your support for this legislation, you are taking a stand for transparency and accountability in the pharmaceutical industry.

In conclusion, the bill introduced by Congressman Paul Gosar has the potential to shake up the pharmaceutical industry and hold companies like Pfizer and Moderna accountable for the safety of their vaccines. It is a bold move that has sparked a lot of discussion and debate. If you believe in the importance of transparency and accountability in the pharmaceutical industry, supporting H.R. 9828 may be a step in the right direction.

Sources:
H.R. 9828 Text
Reuters Article on H.R. 9828